Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
27 Apr 2017
5th Annual ARM Cell&Gene Investor Day, Boston, MA (US)
22 Apr 2017 - 28 Apr 2017
69th American Academy of Neurology Annual Meeting, Boston, MA (US)
01 Apr 2017 - 06 Apr 2017
43rd NANOS Annual Meeting, Washington, DC (US)
09 Jan 2017 - 12 Jan 2017
JP Morgan 35th Annual Healthcare Conference, San Francisco (CA), USA
05 Jan 2017 - 06 Jan 2017
Oddo 20th Forum – Lyon, France
29 Nov 2016 - 30 Nov 2016
Cell Therapy Manufacturing & Gene Therapy, Amsterdam
15 Nov 2016 - 16 Nov 2016
Stifel Healthcare Conference 2016 – New York, NY, USA
07 Nov 2016 - 09 Nov 2016
BioEurope, Cologne, Germany
03 Nov 2016 - 04 Nov 2016
2nd Annual Cell & Gene Therapy Congress, London, UK
18 Oct 2016 - 21 Oct 2016
European Society of Gene and Cell Therapy (ESGCT), Florence, Italy
View previous 9 articles
1
…
8
9
10
11
12
13
14
15
16
17
View next 9 articles
Go back to the page of the page